Clinical Trial Update: Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial compares anti-VEGF monotherapy to anti-VEGF followed by subthreshold micropulse laser for severe diabetic macular edema with central re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Anti-VEGF therapy (various agents) (various anti-VEGF agents)

Snippet

Sponsor: Belfast Health and Social Care Trust | Conditions: Severe Diabetic Macular Oedema | Phase 3 | Status: RECRUITING